Thalidomide-O-amido-C5-NH2|CAS 2360527-40-6|DC Chemicals

Cas No.:	2360527-40-6
Chemical Name:	N-(5-Aminopentyl)-2-[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-4-yl]oxyacetamide;hydrochloride
Synonyms:	N-(5-Aminopentyl)-2-[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-4-yl]oxyacetamide;hydrochloride
SMILES:	Cl.O(CC(NCCCCCN)=O)C1=CC=CC2C(N(C(C=21)=O)C1C(NC(CC1)=O)=O)=O
Formula:	C₂₀H₂₅ClN₄O₆
M.Wt:	452.888704061508
Purity:	>98%
Sotrage:	2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO

MSDS

COA

Cat. No.	Product name	Field of application
DC39625	(S,R,S)-AHPC-PEG4-NH2 hydrochloride	VH 032 Linker 2 is a derivative of the proteolysis-targeting chimera technology (PROTAC) building block VHL ligand 1.
DC50079	Thalidomide-O-amido-C5-NH2	Thalidomide-O-amido-C5-NH2 is a novel PROTAC building block.
DC50078	(S,R,S)-AHPC-Me-C8-NH2	(S,R,S)-AHPC-Me-C8-NH2 is a novel PROTAC building block.
DC50077	(S,R,S)-AHPC-Me-C4-NH2	(S,R,S)-AHPC-Me-C4-NH2 is a novel PROTACA building block.
DC50076	(S,R,S)-AHPC-Me-C3-NH2	(S,R,S)-AHPC-Me-C3-NH2 is a novel PROTAC building block.
DC50075	(S,R,S)-AHPC-Me-C2-NH2	(S,R,S)-AHPC-Me-C2-NH2 is a novel PROTAC building block.
DC50074	(S,R,S)-AHPC-Me-C1-NH2	(S,R,S)-AHPC-Me-C1-NH2 is a novel PROTAC Building block.
DC50070	(S,R,S)-AHPC-PEG2-NH2 (E3 ligase Ligand-Linker Conjugates 6 Free Base)	(S,R,S)-AHPC-PEG2-NH2 (VH032-PEG2-NH2) is a synthesized E3 ligase ligand-linker conjugate that incorporates the (S,R,S)-AHPC based VHL ligand and 2-unit PEG linker used in the synthesis of PROTACs.
DC50069	(S,R,S)-AHPC-PEG4-NH2(E3 ligase Ligand-Linker Conjugates 7)	(S,R,S)-AHPC-PEG4-NH2 is a synthesized E3 ligase ligand-linker conjugate that incorporates the (S,R,S)-AHPC based VHL ligand and 4-unit PEG linker used in PROTAC technology.
DC50068	(S,R,S)-AHPC-Me-C10-NH2	(S,R,S)-AHPC-Me-C10-NH2 is a synthesized E3 ligase ligand-linker conjugate that incorporates the a VHL ligand and a linker. (S,R,S)-AHPC-Me-C10-NH2 can be used in PROTAC MS432